CLINICAL AND BIOCHEMICAL ASPECTS OF DEPRESSIVE-DISORDERS .3. TREATMENT AND CONTROVERSIES

被引：23

作者：

CALDECOTTHAZARD, S

SCHNEIDER, LS

机构：

[1] UNIV CALIF LOS ANGELES, BIOMED & ENVIRONM SCI LAB, LOS ANGELES, CA 90024 USA

[2] UNIV SO CALIF, SCH MED, DEPT PSYCHIAT, LOS ANGELES, CA 90033 USA

来源：

SYNAPSE | 1992年 / 10卷 / 02期

关键词：

DEPRESSIVE DISORDERS; STATE TRAIT MARKERS; ANTIDEPRESSANT DRUGS;

D O I：

10.1002/syn.890100209

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The present document is the final of three parts of a review that focuses on recent data from clinical and animal research concerning the biochemical bases of depressive disorders, diagnosis, and treatment. Various treatments for depression, including psychotherapy, pharmacological, and somatic treatments, will be described in this third part. Also, some of the controversies in the field, as well as a summary of the most salient points of the review, will be discussed. Previous sections of this review dealt with the classification of depressive disorders and research techniques for studying the biochemical mechanisms of these disorders (Part I) and various transmitter/receptor theories of depressive disorder (Part II).

引用

页码：141 / 168

页数：28

共 294 条

[1] COMPARISON BETWEEN ZIMELIDINE AND DESIPRAMINE IN ENDOGENOUS-DEPRESSION - A CROSSOVER STUDY [J].